Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial
Vikram M. Narayan(Emory University), Colin P. Dinney(The University of Texas MD Anderson Cancer Center), Michael A. O’Donnell(University of Iowa Health Care), Thomas J. Guzzo(Hospital of the University of Pennsylvania), Daniel Canter(Ochsner Medical Center), Paul L. Crispen(University of Kentucky), Gennady Bratslavsky(SUNY Upstate Medical University), Tracy M. Downs(University of Wisconsin–Madison), Seppo Ylä‐Herttuala(University of Eastern Finland), Brian R. Lane(Grand Rapids Community College), Michael B. Williams(Eastern Virginia Medical School), Dorte Rehm(Ferring Pharmaceuticals (Denmark)), Lawrence I. Karsh(The Urology Center of Colorado), Joseph Mashni(The University of Texas MD Anderson Cancer Center), Adam Luchey(West Virginia University), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Jørn S. Jakobsen(Ferring Pharmaceuticals (Denmark)), Yair Lotan(Southwestern Medical Center), Nigel Parker(University of Eastern Finland), Seth P. Lerner(Baylor College of Medicine), Brant A. Inman(Duke Medical Center), Michael S. Cookson(University of Oklahoma Health Sciences Center), Gary D. Steinberg(Rush University Medical Center), Gordon Brown(New Jersey Urology), Badrinath R. Konety(Allina Health), Anne Schuckman(University of Southern California), Michael Woods(University of Cambridge), Leonard G. Gomella(Thomas Jefferson University), Trinity J. Bivalacqua(University of Pennsylvania), Stephen A. Boorjian(Mayo Clinic), Michael Poch(Moffitt Cancer Center), Neal D. Shore(Carolina Urologic Research Center), Kristian Vinter Juul(Ferring Pharmaceuticals (Denmark)), Sam S. Chang(Vanderbilt University), Joseph E. Busby(Prisma Health), Alexander I. Sankin(Montefiore Medical Center), Jeffrey S. Montgomery(Ann Arbor Center for Independent Living), Richard Philipson(Parker Hannifin (United Kingdom)), Mehrdad Alemozaffar(Kaiser Permanente), David G. Sawutz
Cited by 80
Related Papers
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
|Journal of Clinical Investigation|1989|1.9k
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
|The Lancet Oncology|2015|1.4k
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k